Product
CKD-498
1 clinical trial
1 indication
Indication
Androgenetic AlopeciaClinical trial
A Phase 2, Randomized, Double-blind, Multi-center, Parallel-group Trial to Evaluate the Efficacy and Safety of CKD-498 in Female Patients With Androgenetic AlopeciaStatus: Recruiting, Estimated PCD: 2024-04-30